| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (IgG Adipo) | # Peptides (by Search Engine): B2 Sequest HT (SelL -/- Adipo) | # Peptides (by Search Engine): C2 Sequest HT | # Peptides (by Search Engine): D2 Sequest HT (Hrd1 -/- Adipo) | # PSMs (by Search Engine): A2 Sequest HT (IgG Adipo) | # PSMs (by Search Engine): B2 Sequest HT (SelL -/- Adipo) | # PSMs (by Search Engine): C2 Sequest HT | # PSMs (by Search Engine): D2 Sequest HT (Hrd1 -/- Adipo) | Abundance: F1: Sample, IgG Adipo | Abundance: F2: Sample, SelL -/- Adipo | Abundance: F3: Sample, WT Adipo | Abundance: F4: Sample, Hrd1 -/- Adipo | Abundances Count: F1: Sample, IgG Adipo | Abundances Count: F2: Sample, SelL -/- Adipo | Abundances Count: F3: Sample, WT Adipo | Abundances Count: F4: Sample, Hrd1 -/- Adipo | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | Q02257 | Junction plakoglobin OS=Mus musculus OX=10090 GN=Jup PE=1 SV=3 | 0 | 22.218 | 13 | 8 | 24 | 8 | 745 | 81.7 | 6.14 | 4 | 8 | 5 | 5 | 6 | 8 | 5 | 5 | 4904960.063 | 6298168.188 | 5948301.875 | 4162443.906 | 8 | 8 | 8 | 7 | cell organization and biogenesis;cellular component movement;regulation of biological process;response to stimulus | cytoplasm;cytoskeleton;cytosol;membrane;nucleus | protein binding;signal transducer activity;structural molecule activity | Pf00514 | 16480 | ENSMUSG00000001552.14 | Jup | 11 | Formation of the cornified envelope; VEGFR2 mediated vascular permeability; Neutrophil degranulation; Adherens junctions interactions | Acute myeloid leukemia; Arrhythmogenic right ventricular cardiomyopathy (ARVC); Transcriptional misregulation in cancer; Pathways in cancer | 0 |